We are live on ! Find out more
EP

Eudaimonia Partners Portfolio holdings

AUM $420M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+27.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$533M
AUM Growth
+$51.4M
Cap. Flow
+$22.5M
Cap. Flow %
4.23%
Top 10 Hldgs %
21.49%
Holding
1,738
New
15
Increased
272
Reduced
69
Closed
1,351

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.28M
2
AMZN icon
Amazon
AMZN
+$4.22M
3
WFC icon
Wells Fargo
WFC
+$4.18M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.42M
5
SCHP icon
Schwab US TIPS ETF
SCHP
+$2.28M

Sector Composition

Rank Sector Weight
1 Technology 13.17%
2 Financials 10.91%
3 Consumer Discretionary 7.06%
4 Industrials 6.8%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNO icon
551
CNO Financial Group
CNO
$4.97B
-10
Closed
CNP icon
552
CenterPoint Energy
CNP
$29B
-3,781
Closed -$86K
CNQ icon
553
Canadian Natural Resources
CNQ
$93.3B
-37
Closed -$1K
CNX icon
554
CNX Resources
CNX
$4.8B
-472
Closed -$7K
COF icon
555
Capital One
COF
$128B
-11
Closed -$1K
COOP
556
DELISTED
Mr. Cooper
COOP
-3
Closed
COR icon
557
Cencora
COR
$61.3B
-1,000
Closed -$118K
CP icon
558
Canadian Pacific Kansas City
CP
$81.2B
-250
Closed -$19K
CPB icon
559
Campbell Soup
CPB
$6.81B
-196
Closed -$10K
CPNG icon
560
Coupang
CPNG
$28.4B
-1,000
Closed -$49K
CPRT icon
561
Copart
CPRT
$28.4B
-272
Closed -$8K
CPRX
562
DELISTED
Catalyst Pharmaceutical
CPRX
-1,000
Closed -$5K
CRBP icon
563
Corbus Pharmaceuticals
CRBP
$169M
-17
Closed -$1K
CRH icon
564
CRH
CRH
$69.2B
-187
Closed -$9K
CRL icon
565
Charles River Laboratories
CRL
$11.5B
-10
Closed -$3K
CRNC icon
566
Cerence
CRNC
$370M
-166
Closed -$15K
CROX icon
567
Crocs
CROX
$6.67B
-85
Closed -$7K
CRSP icon
568
CRISPR Therapeutics
CRSP
$4.61B
-254
Closed -$31K
CRUS icon
569
Cirrus Logic
CRUS
$6.79B
-200
Closed -$17K
CSGS
570
DELISTED
CSG Systems International
CSGS
-15
Closed -$1K
CSQ icon
571
Calamos Strategic Total Return Fund
CSQ
$3.18B
-2,713
Closed -$47K
CTAS icon
572
Cintas
CTAS
$86.5B
-5,988
Closed -$511K
CTSH icon
573
Cognizant
CTSH
$23.3B
-57
Closed -$4K
CTSO icon
574
Cytosorbents Corp
CTSO
$22.6M
-4,000
Closed -$35K
CVLT icon
575
Commault Systems
CVLT
$5.2B
-665
Closed -$43K

Similar funds

Eudaimonia Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Eudaimonia Partners held 1,738 positions worth $533M, up 11% from $482M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Eudaimonia Partners deployed $22.5M of net new capital in Q2 2021, opening 15 new positions and adding to 272 existing holdings. Its largest new stake was American Tower: 7,103 shares worth $1.92M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $2.45M trimmed.

  • Eudaimonia Partners's largest Q2 2021 buy was American Tower: 7,103 shares worth $1.92M.
  • Eudaimonia Partners added most to ExxonMobil in Q2 2021, an estimated $5.28M increase.
  • Eudaimonia Partners's biggest Q2 2021 reduction was Apple, cutting an estimated $2.45M.
  • Eudaimonia Partners fully exited Vanguard Short-Term Treasury ETF in Q2 2021, selling an estimated $946K.
  • Eudaimonia Partners's ten largest holdings make up 21% of its $533M portfolio in Q2 2021.
  • Eudaimonia Partners opened 15 new positions and closed 1,351 in Q2 2021.
  • Eudaimonia Partners's portfolio value rose 11% quarter-over-quarter to $533M.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.